Tinnitus Research and Practice: 2025 Warsaw Congress Highlights
The 2025 World Tinnitus Congress united global experts to explore cutting-edge research, treatments, and technological innovations in tinnitus care.
The 2025 World Tinnitus Congress united global experts to explore cutting-edge research, treatments, and technological innovations in tinnitus care.
Neuromod Devices is expanding access to its Lenire bimodal neuromodulation device, addressing the demand for effective tinnitus treatment.
Lenire’s Spanish launch began in Barcelona. This latest expansion brings the number of clinics in Spain providing Lenire to four.
Widex Canada announced that a recent survey it conducted has revealed that while 58% of primary healthcare providers across Canada see patients with tinnitus on a weekly basis, only 21% of them report referring them to an audiologist, otolaryngologist, or hearing care professional on a regular basis.
The sound quality of Widex PureSound is tailored to people with milder hearing loss, including those with tinnitus.
Oto and Lindus Health announced the launch of a fully remote, digital trial to increase patient access to life-changing tinnitus therapy.